FY22 DAF ACT COVID-19 Commercial Solutions Offering (CSO)
Note: There have been new actions to this contract opportunity. To view the most recent action, please click here.
Looking for contract opportunity help?
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
General Information
- Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
- Original Published Date: Oct 29, 2021 11:55 am CDT
- Original Date Offers Due: Sep 30, 2022 04:00 pm CDT
- Inactive Policy: Manual
- Original Inactive Date: Sep 30, 2022
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code:
- NAICS Code:
- Place of Performance: USA
Description
The Department of the Air Force (DAF) has been tasked to address mission needs in response to the national crisis caused by the Corona Virus Disease 2019 (COVID-19) pandemic. The Air Force Senior Acquisition Executive (SAE) established the Department of the Air Force Acquisition COVID-19 Task Force (DAF ACT) across the acquisition enterprise (i) to execute all requirements from the Office of the Under Secretary of Defense for Defense Assisted Acquisition Cell (DA2) and (ii) to collect and consolidate funding requests needed to recover programs from COVID-19 impacts. The DAF ACT contains four primary lines of effort (LOE’s)
LOE’s: (1) Relief for external assistance requirements; (2) Resilience for Defense Industrial Base Efforts; (3) Recovery for consolidating funding requests that minimize program impacts; and (4) Rapid for solicitation and execution of large-scale rapid small business contracts across all lines of effort.
As the U.S. Government response to the COVID-19 pandemic has evolved, the DA2 mission has also evolved to include the replenishment of the Strategic National Stockpile (SNS) and expand and preserve the domestic manufacture of key medical personnel protective equipment (PPE) items, screening and diagnostics instruments and supplies, finished drugs and active pharmaceutical ingredients and the associated finishing and delivery capabilities. The Department of the Air Force Acquisition Task Force combined with the DA2, will lead rapid solicitation and execution of contracts in support of the DA2 mission.
This CSO announcement anticipates soliciting solution briefs through separate and periodically published Areas of Interest (AOI) to meet Department of Health and Human Services (HHS) COVID-19 response priorities, with an emphasis on SNS goals that achieve (1) more coverage to ensure sufficient inventory of major PPE, equipment and drugs associated with COVID-like pandemics, (2) greater insight to forecast requirements, (3) use various inventory management strategies and improved visibility into supply and demand, and (4) enhance manufacturing capacity to reduce dependency on foreign sources of supply.
The CSO is a streamlined acquisition process that seeks to reduce acquisition timelines and acquire new, innovative solutions that companies can bring forth to meet the stated AoIs. All details of the process shall be governed by this CSO unless otherwise noted or expanded upon in each AoI. Complete CSO details are contained in the attached document "FY22 DAF ACT COVID-19 Commercial Solutions Offering (CSO)" below.
Interested parties should continue to monitor this Notice for updated information and publication of specific AoIs.
Attachments/Links
Contact Information
Primary Point of Contact
- April Davison
- cso.dafact.covid@afwerx.af.mil
- Phone Number 937-210-9860
Secondary Point of Contact
- Anna Mroz
- cso.dafact.covid@afwerx.af.mil
- Phone Number 405-734-4629